Glenn Jeffrey S 4
4 · Eiger BioPharmaceuticals, Inc. · Filed Dec 27, 2022
Insider Transaction Report
Form 4
Glenn Jeffrey S
Director
Transactions
- Purchase
Common Stock
2022-12-22$1.28/sh+100,000$127,950→ 182,355 total
Holdings
- 5,000(indirect: By Spouse)
Common Stock
- 151,064(indirect: By Eiger Group International, Inc.)
Common Stock
- 460(indirect: By son)
Common Stock
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.18 to $1.30, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
- [F2]Shares are held by Eiger Group International, Inc. ("EGI"). The Reporting Person is the Chief Executive Officer of EGI and has sole power to vote and sole power to dispose of shares directly owned by EGI. The Reporting Person disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein.